Calcific uraemic arteriolopathy in a patient with end‐stage renal failure and chronic plaque psoriasis: could TNF‐α inhibition help ameliorate disease progression?

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-0960|56|1|68-69

ISSN： 0004-8380

Source： AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol.56, Iss.1, 2015-02, pp. : 68-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Nephropathies: Individual Risk for Progression to End-Stage Renal Failure as Predicted by an Integrated Probabilistic Model

By  

Nephron Clin Pract, Vol. 95, Iss. 2, 2004-11 ,pp. : c47-c59

Karger

Access to resources Recommend Favorite

Markers of Arterial Stiffness Are Risk Factors for Progression to End-Stage Renal Disease among Patients with Chronic Kidney Disease Stages 4 and 5

By  

Nephron Clin Pract, Vol. 107, Iss. 4, 2007-11 ,pp. : c177-c181

Karger

Access to resources Recommend Favorite

Management of end-stage renal failure

By Al-Mosawi Aamir Jalal  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 307-309

Future Medicine

Access to resources Recommend Favorite

Fabry Disease in Patients with End-Stage Renal Failure: The Potential Benefits of Screening

By  

Nephron Clin Pract, Vol. 101, Iss. 1, 2005-05 ,pp. : c33-c38

Karger

Access to resources Recommend Favorite

Outcomes of Stage 3–5 Chronic Kidney Disease before End-Stage Renal Disease at a Single Center in Taiwan

By  

Nephron Clin Pract, Vol. 109, Iss. 3, 2008-07 ,pp. : c109-c118

Karger

Access to resources Recommend Favorite